Peng Zhao - China Life Ex Director
| 601628 Stock | 39.20 0.79 1.98% |
Director
Peng Zhao is Ex Director of China Life Insurance
| Age | 51 |
| Address | 16 Financial Street, Beijing, China, 100033 |
| Phone | 86 10 6363 3333 |
| Web | https://www.e-chinalife.com |
China Life Management Efficiency
The current year's Other Current Assets is expected to grow to about 61.2 B, whereas Total Assets are forecasted to decline to about 3.9 T. China Life's management efficiency ratios could be used to measure how well China Life manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Zhiying Chen | Shenzhen Bioeasy Biotechnology | 57 | |
| Hehua Lu | Shenzhen Bioeasy Biotechnology | 40 | |
| Wenhao Yan | Shenzhen Bioeasy Biotechnology | 46 | |
| Jianke Pei | Hunan Investment Group | 57 | |
| Aihua Wang | Bloomage Biotechnology Corp | 46 | |
| Aihua Liu | Bloomage Biotechnology Corp | 62 | |
| Jianfeng Wang | Jointo Energy Investment | 57 | |
| Hui Wang | Bloomage Biotechnology Corp | 42 | |
| Kaihui Wang | Guangdong Marubi Biotechnology | 53 | |
| Jianguo Xia | Jiangsu GDK Biotechnology | 51 | |
| Lingli Lin | Bloomage Biotechnology Corp | 53 | |
| Sha Peng | Hunan Investment Group | 47 | |
| Xiaosong Chen | Hunan Investment Group | 60 | |
| Zhixia Hu | Jiangsu GDK Biotechnology | 43 | |
| Qiang Huang | Jiangsu GDK Biotechnology | 45 | |
| Xueping Guo | Bloomage Biotechnology Corp | 60 | |
| Zening Wang | Fujian Wanchen Biotechnology | 32 | |
| Lingchun Zeng | Guangdong Marubi Biotechnology | 47 | |
| Hui Fu | Shenzhen Bioeasy Biotechnology | 40 | |
| Keke Chen | Hunan Investment Group | 48 | |
| Jiajun Guo | Bloomage Biotechnology Corp | 50 | |
Management Performance
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0091 |
China Life Insurance Leadership Team
Elected by the shareholders, the China Life's board of directors comprises two types of representatives: China Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Life's management team and ensure that shareholders' interests are well served. China Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ying Yuan, Chief Officer | ||
| Ja CPA, Company Secretary | ||
| Ruan Qi, VP Officer | ||
| Guodong Zhao, Board President | ||
| Jin Hou, Chief Department | ||
| Hui Liu, Executive Director | ||
| Chongmiao Xu, Chief Compliance | ||
| Kai Bai, Assistant President | ||
| Grace Hou, Investor Executive | ||
| Mingguang Li, Executive President | ||
| Di Zhang, Assistant Officer | ||
| Tao Bai, Executive Chairman | ||
| Qun Huo, Assistant President | ||
| Liu Hui, Chief VP | ||
| Xiliang Cai, Executive Secretary | ||
| Peng Zhao, Ex Director | ||
| Yuejin Liu, Assistant Pres | ||
| Hong Yang, Operating VP | ||
| Zhong Zhan, Marketing VP |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0091 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.67 % | ||||
| Current Valuation | 894.85 B | ||||
| Shares Outstanding | 20.82 B | ||||
| Shares Owned By Insiders | 0.56 % | ||||
| Shares Owned By Institutions | 93.77 % | ||||
| Price To Book | 1.96 X | ||||
| Price To Sales | 1.14 X |
Currently Active Assets on Macroaxis
Other Information on Investing in China Stock
China Life financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Life security.